Adaptimmune Therapeutics (ADAP) Institutional Ownership $0.51 -0.03 (-5.43%) Closing price 04:00 PM EasternExtended Trading$0.52 +0.01 (+2.80%) As of 05:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Adaptimmune Therapeutics (NASDAQ:ADAP)CurrentInstitutional OwnershipPercentage31.37%Number ofInstitutional Buyers(last 12 months)19TotalInstitutional Inflows(last 12 months)$24.68MNumber ofInstitutional Sellers(last 12 months)9TotalInstitutional Outflows(last 12 months)$6.92M Get ADAP Insider Trade Alerts Want to know when executives and insiders are buying or selling Adaptimmune Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ADAP Institutional Buying and Selling by Quarter Adaptimmune Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/18/2025 Two Seas Capital LP14,835,146$7.99M0.6%N/A5.798% 2/17/2025 Two Sigma Investments LP76,347$41K0.0%+33.5%0.030% 2/17/2025 Two Sigma Advisers LP70,735$38K0.0%+492.0%0.028% 2/17/2025 Bank of America Corp DE2,862,330$1.54M0.0%-38.5%1.119% 2/14/2025 Jane Street Group LLC326,937$176K0.0%+87.7%0.128% 2/14/2025 Two Seas Capital LP14,835,146$7.99M0.7%N/A5.798% 2/14/2025 Long Focus Capital Management LLC20,494,393$11.04M0.4%+54.1%8.009% 2/14/2025 Rock Springs Capital Management LP2,483,468$1.34M0.1%+2.4%0.971% 2/13/2025 Renaissance Technologies LLC2,526,524$1.36M0.0%+52.5%0.987% 2/13/2025 Invesco Ltd.63,335$34K0.0%+82.0%0.025% Get the Latest News and Ratings for ADAP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Adaptimmune Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/12/2025 JPMorgan Chase & Co.916,941$494K0.0%-12.3%0.358% 2/11/2025 LPL Financial LLC183,479$99K0.0%+106.5%0.072% 2/11/2025 Virtu Financial LLC122,696$66K0.0%+21.5%0.048% 1/31/2025 Baillie Gifford & Co.11,819,095$6.37M0.0%-29.5%4.619% 11/20/2024 Virtu Financial LLC101,008$96K0.0%+27.5%0.039% 11/15/2024 Jane Street Group LLC174,157$166K0.0%+130.4%0.068% 11/15/2024 Matrix Capital Management Company LP37,681,515$35.81M1.7%-3.3%14.734% 11/14/2024 PFM Health Sciences LP10,000,787$9.51M0.5%-4.9%3.911% 11/13/2024 FMR LLC1,740,900$1.66M0.0%+3.0%0.681% 11/5/2024 Baillie Gifford & Co.16,775,860$15.94M0.0%+10.7%6.560% 11/5/2024 GSA Capital Partners LLP99,662$95K0.0%N/A0.039% 10/29/2024 Fullcircle Wealth LLC35,000$33K0.0%N/A0.014% 10/16/2024 Vontobel Holding Ltd.43,000$41K0.0%+230.8%0.017% 8/15/2024 Long Focus Capital Management LLC12,346,417$12.04M0.5%+15.6%5.002% 8/14/2024 Marshall Wace LLP144,880$141K0.0%-43.0%0.059% 8/9/2024 Renaissance Technologies LLC1,786,341$1.74M0.0%+28.3%0.724% 7/25/2024 Baillie Gifford & Co.15,149,203$14.77M0.0%-4.6%6.138% 5/15/2024 Baker BROS. Advisors LP10,787,022$17.04M0.2%-1.7%4.370% 5/14/2024 Boulder Hill Capital Management LP90,800$143K0.1%N/A0.037% 5/3/2024 GSA Capital Partners LLP370,179$585K0.0%-27.2%0.150% 5/1/2024 Baillie Gifford & Co.15,871,875$25.08M0.0%-0.3%6.431% 4/19/2024 JTC Employer Solutions Trustee Ltd26,156$41K0.0%N/A0.003% 4/15/2024 Key Client Fiduciary Advisors LLC268,655$424K0.2%-20.2%0.027% 4/15/2024 Columbia Advisory Partners LLC15,585$25K0.0%N/A0.002% 3/5/2024 Twin Focus Capital Partners LLC55,526$44K0.0%N/A0.006% 1/26/2024 Baillie Gifford & Co.15,912,140$12.62M0.0%-7.2%1.600% 1/9/2024 Key Client Fiduciary Advisors LLC336,620$267K0.2%+6.4%0.034% 1/8/2024 Harbor Capital Advisors Inc.147,732$117K0.0%+9.9%0.015% 11/13/2023 Baillie Gifford & Co.17,147,409$13.38M0.0%-0.2%1.725% 10/27/2023 Marquette Asset Management LLC99,349$77K0.0%N/A0.010% A deadly mistake in my prediction… (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you.10/27/2023 Acuitas Investments LLC479,764$374K0.2%N/A0.048% 10/20/2023 Harbor Capital Advisors Inc.134,415$105K0.0%+19.5%0.014% 9/21/2023 Barclays PLC50,061$46K0.0%N/A0.005% 9/7/2023 MPM Asset Management LLC6,287,101$5.82M2.9%N/A0.632% 8/15/2023 Black Maple Capital Management LP69,839$65K0.0%N/A0.007% 8/14/2023 X Square Capital LLC26,771$25K0.0%N/A0.003% 8/14/2023 CSS LLC IL90,702$84K0.0%N/A0.009% 8/11/2023 Artal Group S.A.1,133,775$1.05M0.0%N/A0.114% 8/7/2023 Acadian Asset Management LLC358,010$329K0.0%+15.1%0.036% 8/3/2023 Oppenheimer & Co. Inc.68,171$63K0.0%N/A0.007% 7/28/2023 Baillie Gifford & Co.17,176,135$15.89M0.0%+0.4%1.728% 7/11/2023 Harbor Capital Advisors Inc.112,516$104K0.0%N/A0.073% 5/17/2023 Long Focus Capital Management LLC5,435,439$5.93M0.3%+2.9%3.514% 5/12/2023 Long Focus Capital Management LLC2,772,791$3.02M0.3%-47.5%1.793% 5/10/2023 Simplify Asset Management Inc.150,000$164K0.0%N/A0.097% 5/3/2023 Baillie Gifford & Co.17,112,002$18.65M0.0%-0.3%11.064% 5/1/2023 Virtu Financial LLC88,234$96K0.0%+193.1%0.057% 4/25/2023 Key Client Fiduciary Advisors LLC321,155$350K0.2%+8.2%0.208% 2/15/2023Endurant Capital Management LP1,733,236$2.53M1.0%-3.1%1.058% 2/14/2023 Susquehanna International Group LLP28,126$41K0.0%N/A0.017% 2/9/2023 HBK Sorce Advisory LLC70,000$65K0.0%+100.0%0.043% 1/17/2023 Key Client Fiduciary Advisors LLC296,740$433K0.3%-31.9%0.181% 1/11/2023 Vigilare Wealth Management28,800$42K0.0%-21.7%0.018% 11/15/2022 PFM Health Sciences LP9,320,584$10.02M0.4%+2.3%5.689% 11/15/2022 Long Focus Capital Management LLC4,789,490$5.15M0.5%+2.4%2.923% 11/15/2022Endurant Capital Management LP1,788,517$1.92M0.6%-1.9%1.092% 11/14/2022 HBK Sorce Advisory LLC35,000$32K0.0%N/A0.021% 11/10/2022 ExodusPoint Capital Management LP370,288$398K0.0%+23.4%0.227% 11/7/2022 Virtu Financial LLC40,503$44K0.0%+133.7%0.025% 11/3/2022 Barclays PLC340,068$366K0.0%+34.6%0.208% 10/27/2022 Baillie Gifford & Co.14,664,936$15.76M0.0%-4.3%8.977% 10/12/2022 Key Client Fiduciary Advisors LLC435,985$469K0.4%+4.8%0.267% 8/12/2022 Rafferty Asset Management LLC217,123$369K0.0%-59.5%0.134% 8/11/2022 Alps Advisors Inc.96,110$163K0.0%N/A0.059% 8/10/2022 Hunter Associates Investment Management LLC28,500$49K0.0%+42.5%0.018% 8/8/2022 Baillie Gifford & Co.15,321,346$26.05M0.0%-0.4%9.457% 7/11/2022 Vigilare Wealth Management41,800$71K0.1%N/A0.026% 5/17/2022Endurant Capital Management LP2,160,890$4.45M1.2%+140.7%1.335% 5/16/2022 Eversept Partners LP237,086$488K0.0%-32.0%0.151% 5/11/2022 GSA Capital Partners LLP69,612$143K0.0%-17.3%0.044% 5/5/2022 Baillie Gifford & Co.15,380,538$31.68M0.0%+11.8%9.805% 5/5/2022Levy Wealth Management Group LLC17,590$36K0.0%N/A0.011% 4/29/2022 Daiwa Securities Group Inc.35,516$73K0.0%+44.9%0.023% 4/26/2022 Hunter Associates Investment Management LLC20,000$41K0.0%+81.8%0.013% 4/21/2022 Inspire Investing LLC31,928$66K0.0%+107.4%0.020% 4/21/2022 Inspire Advisors LLC45,105$93K0.0%+193.0%0.029% 4/18/2022 Key Client Fiduciary Advisors LLC420,447$866K0.7%+58.0%0.268% 2/14/2022 Long Focus Capital Management LLC2,162,313$8.11M1.1%N/A1.384% 2/14/2022 Point72 Asset Management L.P.565,208$2.12M0.0%+640.8%0.362% 2/14/2022 DAFNA Capital Management LLC136,266$511K0.1%N/A0.087% Has Trump finally met his match? (Ad)Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance to walk away with gains as high as 235%, 459%, and 700% - all while the stock market got cut in half. Could he be right again?Click here for his emergency broadcast...2/14/2022 Eversept Partners LP348,716$1.31M0.1%-21.6%0.223% 2/14/2022 GSA Capital Partners LLP84,129$315K0.0%-82.6%0.054% 2/11/2022 Syncona Portfolio Ltd1,377,294$5.17M4.9%N/A0.882% 2/10/2022 Rafferty Asset Management LLC606,763$2.28M0.0%-18.1%0.388% 2/8/2022 Bank of America Corp DE538,111$2.02M0.0%-26.5%0.344% 2/8/2022 ProShare Advisors LLC19,315$72K0.0%-34.0%0.012% 2/7/2022 Mitsubishi UFJ Kokusai Asset Management Co. Ltd.69,140$281K0.0%+13.6%0.044% 2/3/2022 Daiwa Securities Group Inc.24,515$92K0.0%+59.4%0.016% 2/3/2022 Inspire Investing LLC15,393$58K0.0%N/A0.010% 1/27/2022 Hunter Associates Investment Management LLC11,000$41K0.0%N/A0.007% (Data available from 1/1/2016 forward) ADAP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ADAP shares? During the previous two years, 38 institutional investors and hedge funds held shares of Adaptimmune Therapeutics. The most heavily invested institutionals were Matrix Capital Management Company LP ($35.81M), Baker BROS. Advisors LP ($17.04M), Long Focus Capital Management LLC ($11.04M), PFM Health Sciences LP ($9.51M), Two Seas Capital LP ($7.99M), Baillie Gifford & Co. ($6.37M), and MPM Asset Management LLC ($5.82M).Learn more on ADAP's institutional investors. What percentage of Adaptimmune Therapeutics stock is owned by institutional investors? 31.37% of Adaptimmune Therapeutics stock is owned by institutional investors. Learn more on ADAP's institutional investor holdings. Which institutional investors have been buying Adaptimmune Therapeutics stock? Of the 32 institutional investors that purchased Adaptimmune Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Two Seas Capital LP ($29.67M), Long Focus Capital Management LLC ($9.01M), MPM Asset Management LLC ($6.29M), Baillie Gifford & Co. ($1.69M), Renaissance Technologies LLC ($1.26M), Artal Group S.A. ($1.13M), and Acuitas Investments LLC ($479.76K). How much institutional buying is happening at Adaptimmune Therapeutics? Institutional investors have bought a total of 51,344,323 shares in the last 24 months. This purchase volume represents approximately $32.95M in transactions. Which Adaptimmune Therapeutics major shareholders have been selling company stock? Of the 10 institutional investors that sold Adaptimmune Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Baillie Gifford & Co. ($7.04M), Long Focus Capital Management LLC ($2.51M), Bank of America Corp DE ($1.79M), Matrix Capital Management Company LP ($1.29M), PFM Health Sciences LP ($519.44K), Baker BROS. Advisors LP ($182.26K), and GSA Capital Partners LLP ($138.63K). How much institutional selling is happening at Adaptimmune Therapeutics? Institutional investors have sold a total of 13,782,170 shares in the last 24 months. This volume of shares sold represents approximately $10.72M in transactions. Related Companies QURE Major Shareholders XERS Major Shareholders MGTX Major Shareholders IMTX Major Shareholders ORIC Major Shareholders MNMD Major Shareholders ANAB Major Shareholders KALV Major Shareholders PGEN Major Shareholders CGEM Major Shareholders This page (NASDAQ:ADAP) was last updated on 3/3/2025 by MarketBeat.com Staff From Our PartnersDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredThe Deep State Surveillance Plot To Sabotage President TrumpThere's a Trump approved IRS-loophole which allows you to steer clear of government overreach and move your re...American Hartford Gold | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredUrgent update to my gold outlookTrump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored3 Undervalued Stocks to Get Today (Revealed)These 3 Stocks Should Do Well Even in a Recession If you’re looking for stocks that offer significant upsid...StockEarnings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adaptimmune Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Adaptimmune Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
